Literature DB >> 31515044

The "six-and-twelve score" for TACE treatment: Does it really help us?

Marc Bourlière1, Guillaume Pénaranda2, Xavier Adhoute3, Jean-Pierre Bronowicki4.   

Abstract

Entities:  

Keywords:  Hepatocellular carcinoma; Prognosis; Scoring system; Transarterial chemoembolization

Mesh：

Year:  2019        PMID： 31515044     DOI： 10.1016/j.jhep.2019.06.014

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  4 in total

Review 1.  Local and Regional Therapies for Hepatocellular Carcinoma and Future Combinations.

Authors:  Adam Hatzidakis; Lukas Müller; Miltiadis Krokidis; Roman Kloeckner
Journal:  Cancers (Basel)       Date:  2022-05-17       Impact factor: 6.575

2.  Tumor Burden in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Head-to-Head Comparison of Current Scoring Systems.

Authors:  Lukas Müller; Felix Hahn; Timo Alexander Auer; Uli Fehrenbach; Bernhard Gebauer; Johannes Haubold; Sebastian Zensen; Moon-Sung Kim; Michel Eisenblätter; Thierno D Diallo; Dominik Bettinger; Verena Steinle; De-Hua Chang; David Zopfs; Daniel Pinto Dos Santos; Roman Kloeckner
Journal:  Front Oncol       Date:  2022-02-23       Impact factor: 6.244

3.  The combination of sarcopenia and biochemical factors can predict the survival of hepatocellular carcinoma patients receiving transarterial chemoembolization.

Authors:  Tzu-Ping Chien; Song-Fong Huang; Wen-Hui Chan; Kuang-Tse Pan; Ming-Chin Yu; Wei-Chen Lee; Hsin-I Tsai; Po-Ting Lin; Hsing-Yu Chen; Jui-Hsuan Chen; Chao-Wei Lee
Journal:  Front Oncol       Date:  2022-09-29       Impact factor: 5.738

4.  "Six-and-twelve" score for outcome prediction of hepatocellular carcinoma following transarterial chemoembolization. In-depth analysis from a multicenter French cohort.

Authors:  Xavier Adhoute; Guillaume Pénaranda; Jean-Luc Raoul; Jean-Pierre Bronowicki; Rodolphe Anty; Marc Bourlière
Journal:  World J Hepatol       Date:  2020-08-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.